More Care Guides Browse by topicAll guidesBenefits & Allowances (17)Equipment & Devices (17)Home Care & CDPAP (11)Appeals & Denials (5)Bills & Costs (6)Medications (7)Plans & Coverage (6)Living With a Condition (6)Working With an Advocate (12)Medications · Aug 7, 2026What Is the Medicare GLP-1 Bridge Program and Who Qualifies?The Medicare GLP-1 Bridge covers Wegovy, Zepbound KwikPen and Foundayo at $50/month. Learn who qualifies by BMI tier, which drugs are covered, and how to apply.Medications · Jul 24, 2026How to Get GLP-1 and Neuropathy Medication Covered on the Same Medicare PlanFind out how to get both GLP-1 weight-loss drugs and neuropathy medications covered on the same Medicare plan - two separate tracks, one coordinated approach.Medications · Jul 18, 2026EPIC in New York: Who Qualifies and How Much It Cuts Your Prescription CostsNew York's EPIC program lowers drug costs for residents 65+ on Medicare Part D. Income limits for the Fee and Deductible plans, copay tiers, and how to enroll.Medications · Jul 1, 2026Why the GLP-1 Drug You Were Approved For Suddenly Costs $1,200 Instead of the Promised $50The short answer: insurance approval for a GLP-1 drug like Wegovy or Ozempic refers to medical authorization - not a guarantee of the price printed in your plan's summary of benefits.Medications · Jun 30, 2026GLP-1 Bridge Program vs Compounded Semaglutide: Real CostsMedicare's GLP-1 Bridge - which refers to the CMS demonstration program covering Wegovy and Zepbound launched July 1, 2026 - offers a $50 monthly copay that undercuts compounded semaglutide at every dose level.Medications · Jun 5, 2026GLP-1 Side Effects on Medicare: When to Call Your Advocate vs Your DoctorGLP-1 side effects on Medicare fall into two categories: clinical symptoms that require a doctor, and coverage problems that require a patient advocate - and confusing the two costs patients weeks of medication access they cannot afford to lose.Medications · Jun 3, 2026How a Patient Advocate Helps Medicare Patients Get GLP-1 Drugs Covered (Ozempic, Wegovy, Mounjaro)Medicare's GLP-1 Bridge Program brings Wegovy and Zepbound to a $50 copay in 2026. Who qualifies, why prior authorization fails, and how an advocate gets it approved.